284: METHYLPREDNISOLONE VERSUS USUAL CARE FOR COVID-19-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME.

MLA

Owusu, Kent, et al. “284: Methylprednisolone Versus Usual Care for Covid-19-Associated Acute Respiratory Distress Syndrome.” Critical Care Medicine, vol. 50, Jan. 2022, p. 127. EBSCOhost, https://doi.org/10.1097/01.ccm.0000807460.83646.b2.

APA

Owusu, K., Ammar, M., Ammar, A., Chess, A., Siner, J., Fajardo, E., & Chichra, A. (2022). 284: Methylprednisolone Versus Usual Care for Covid-19-Associated Acute Respiratory Distress Syndrome. Critical Care Medicine, 50, 127. https://doi.org/10.1097/01.ccm.0000807460.83646.b2

Chicago

Owusu, Kent, Mahmoud Ammar, Abdalla Ammar, Adam Chess, Jonathan Siner, Elaine Fajardo, and Astha Chichra. 2022. “284: Methylprednisolone Versus Usual Care for Covid-19-Associated Acute Respiratory Distress Syndrome.” Critical Care Medicine 50 (January): 127. doi:10.1097/01.ccm.0000807460.83646.b2.